Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC...

Area of Science:

• Biochemistry
• Molecular Biology
• Cellular Signaling

Background:

• Casein Kinase 2 (CSNK2) is a vital enzyme regulating numerous cellular processes.
• Identifying CSNK2 substrates is crucial for understanding its role in cell signaling.
• Existing ATP-competitive inhibitors have limitations due to off-target effects.

Purpose of the Study:

• To develop a robust strategy for definitive identification and validation of CSNK2 kinase-substrate relationships.
• To overcome the limitations of current inhibitor-based methods for phosphoproteome mapping.

Main Methods:

• Engineered U2OS cells expressing wild-type (WT) or a triple mutant (TM) CSNK2A1 resistant to the inhibitor CX-4945.
• Utilized triple SILAC quantitative phosphoproteomics to analyze cells treated with CX-4945.
• Compared phosphorylation patterns between WT and TM CSNK2A1 expressing cells.

Main Results:

• The CSNK2A1-TM mutant retained kinase activity in the presence of CX-4945, unlike WT CSNK2A1.
• Identified and validated several CSNK2-dependent substrates based on increased phosphorylation in CSNK2A1-TM cells.
• Demonstrated the efficacy of the combined chemical genetics and phosphoproteomics strategy.

Conclusions:

• The developed strategy effectively identifies and validates kinase substrates, overcoming inhibitor limitations.
• This approach provides a reliable method for mapping kinase-dependent phosphoproteomes.
• The strategy is adaptable for identifying substrate relationships for other kinases.